Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 6, 2014Leukemia & lymphoma/Leukemia and lymphoma

Health utilities in relation to treatment response and adverse events in relapsed/refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPaul SwinburnSSS.L. ShinglerSASarah Acaster

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Swinburn et al. (2014) studied this question.

synapsesocial.com/papers/6a79e49d4c448619ca0ded04https://doi.org/10.3109/10428194.2014.970542
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study2010 · 108 citations
  2. 2The time trade-off method: Results from a general population study1996 · 701 citations
  3. 3Health state utilities for non small cell lung cancer2008 · 405 citations
  4. 4Fatigue in Long-Term Hodgkin's Disease Survivors: A Follow-Up Study2005 · 126 citations
  5. 5A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes2008 · 70 citations